Showing results (921-930 of 6,025) with videos related to
Sort By:
Pageof 603
Cellular Signalling|August 23, 2008
Serine 396 of PDK1 is required for maximal PKB activationZoe Moon, Yanping Wang, Nathan Aryan, et al.Viruses|October 14, 2011
Core as a novel viral target for hepatitis C drugsArthur Donny Strosberg, Smitha Kota, Virginia Takahashi, et al.Journal of Chemical Theory and Computation|November 25, 2015
Use of Umbrella Sampling to Calculate the Entrance/Exit Pathway for Z-Pro-Prolinal Inhibitor in Prolyl OligopeptidaseJean-François St-Pierre, Mikko Karttunen, Normand Mousseau, et al.Scientific Reports|January 28, 2016
Fitness costs of increased cataract frequency and cumulative radiation dose in natural mammalian populations from ChernobylPhilipp Lehmann, Zbyszek Boratyński, Tapio Mappes, et al.Scientific Reports|November 22, 2014
Increased radiation from Chernobyl decreases the expression of red colouration in natural populations of bank voles (Myodes glareolus)Zbyszek Boratyński, Philipp Lehmann, Tapio Mappes, et al.Plos Pathogens|January 7, 2021
The genetic proteome: Using genetics to inform the proteome of mycobacterial pathogensKathleen R Nicholson, C Bruce Mousseau, Matthew M Champion, et al.Journal of the American Society for Mass Spectrometry|July 10, 2024
Quenching Trypsin Is Unnecessary in Filter-Based Bottom-Up ProteomicsC Bruce Mousseau, Daniel D Hu, Sadie R Schultz, et al.Journal of the American Geriatrics Society|June 29, 2016
Antileukotriene Agents Versus Long-Acting Beta-Agonists in Older Adults with Persistent Asthma: A Comparison of Add-On TherapiesShoroq M Altawalbeh, Carolyn T Thorpe, Janice C Zgibor, et al.Journal of Managed Care & Specialty Pharmacy|April 26, 2018
Economic Burden Associated with Receiving Inhaled Corticosteroids with Leukotriene Receptor Antagonists or Long-Acting Beta Agonists as Combination Therapy in Older AdultsShoroq M Altawalbeh, Carolyn T Thorpe, Janice C Zgibor, et al.Vox Sanguinis|May 10, 2005
International collaborative study to evaluate a candidate reference preparation to define an appropriate specified limit of anti-D in intravenous immunoglobulin productsS J Thorpe, B Fox, A Heath, et al.Pageof 603